BioGredient II ApS: Financial statements 2017
CVR: 37759724
Source: annual report 2017, Danish Business Authority
26/05/2016 – 30/06/2017
BioGredient II ApS (CVR 37759724) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -10,000. Equity in the 2017 report amounted to DKK 40,000. The solvency ratio was 80%.
- Profit/Loss
- DKK -10,000
- Equity
- DKK 40,000
- Total Assets
- DKK 50,000
Official annual report
Keep an eye on BioGredient II ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of April 12, 2017, Orla Møller Petersen is registered as adm. dir. of BioGredient II ApS.
As of April 12, 2017, Gunnar Kvistgaard has stepped down as director of BioGredient II ApS.
About BioGredient II ApS
BioGredient II ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is in liquidation. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Nordic-Umami ApS. The management consists of Anders Hoffmann Kønigsfeldt. The company is owned by DACWR ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK -14,447.